E-ISSN 2757-8062
Volume: 53 Issue: 2 Year: 2022

Quick Search




Perinatal Outcomes of 91 Cases of Non-Immune Hydrops Fetalis [Zeynep Kamil Med J]
Zeynep Kamil Med J. Ahead of Print: ZKMJ-90377

Perinatal Outcomes of 91 Cases of Non-Immune Hydrops Fetalis

Emre Erdoğdu1, Resul Arisoy2, Lütfiye Uygur3, Furkan Kayabaşoğlu1, Sevcan Arzu Arinkan4, Oya Gokcer3, Murat Muhcu5
1Alle Health Clinic, Department of Perinatology, Istanbul, Turkey
2Atasehir Memorial Hospital, Department of Perinatology, Istanbul, Turkey
3Zeynep Kamil Gynecologic and Pediatric Training and Research Hospital, Istanbul, Turkey
4Haydarpasa Training and Research Hospital, Istanbul, Turkey
5Umraniye Training and Research Hospital, Istanbul, Turkey

INTRODUCTION: We aimed to investigate the proportion of etiologically identified non-immune hydrops fetalis cases and perinatal outcomes of all the cases that were diagnosed and managed in a single tertiary perinatal center over a 7-year period
METHODS: Perinatal outcomes, background disorders, and clinical details of the patient and the surviving fetus were retrospectively analyzed.
RESULTS: The etiology was identified prenatally in 60 (65.9%) out of 91 cases. Cystic hygromas and cardiac abnormalities were the most common identifiable causes. Of 91 cases, 48 (52.7%) elected to terminate their pregnancy. Among the 43 patients who elected to continue with their pregnancy, 12 (27.9%) resulted in intrauterine fetal death and 31 (72.1%) survived to birth. The survival rate at discharge was 23.2%.
DISCUSSION AND CONCLUSION: Non-immune hydrops fetalis is a complex problem associated with high mortality. Many patients elect the termination of their pregnancy, and the survival rate is 23.2% in cases who elect to continue with their pregnancy.

Keywords: Non-immune hydrops fetalis, perinatal outcome, survival



Corresponding Author: Lütfiye Uygur, Türkiye
Manuscript Language: English
LookUs & Online Makale